Compare TG Therapeutics Inc (TGTX) vs Thomson Reuters Corp (TRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Thomson Reuters Corp — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Thomson Reuters Corp trades at $90.9 (market cap $41.28B). The key difference: Thomson Reuters Corp is far larger — about 5× TG Therapeutics Inc's market cap, and Thomson Reuters Corp pays a 2.75% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | TRI | |
|---|---|---|
Market Cap | $8.26B | $41.28B |
Sector | Health | Industrials |
52-Week High | $59.06 | $205.54 |
52-Week Low | $26.39 | $76.55 |
Enterprise Value | $8.50B | $43.24B |
Dividend Yield | — | 2.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →
